Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.32 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.32 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13730363 | 0.89 | ALDH1A1 (0.39) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL988084 | 0.86 | HSD17B10 (0.41) | ALDH1A1TDP1HDAC11TSHR | |
| Hydrochloric Acid SCHEMBL1249049 | 0.84 | HSD17B10 (0.40) | ALDH1A1TDP1HDAC11TSHR | |
| SCHEMBL1286932 | 0.84 | ALDH1A1 (0.43) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| Ethylene SCHEMBL31337284 | 0.83 | HSD17B10 (0.39) | ALDH1A1TDP1HDAC11TSHR | |
| SCHEMBL17461346 | 0.83 | CYP1A2 (0.47) | ALDH1A1TDP1HDAC3HDAC4HDAC1 | |
| SCHEMBL10030117 | 0.83 | TDP1 (0.47) | ALDH1A1TDP1HDAC3HDAC4HDAC1 | |
| Methoxymethane SCHEMBL30701424 | 0.82 | HSD17B10 (0.38) | ALDH1A1TDP1HDAC11TSHR | |
| SCHEMBL17764215 | 0.80 | BLM (0.36) | ALDH1A1TDP1HDAC11TSHR | |
| SCHEMBL760267 | 0.79 | ALDH1A1 (0.52) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109734925-B | Polymer fluorescence sensor for detecting hypochlorite based on porphyrin comparability, preparation method and application | 湖南科技大学 | 2021-02-02 | — | — | CN | claimed |
| EP-4719445-A1 | PHAGE-EXTRACELLULAR VESICLE CONJUGATE | The University Of Sydney (AU) | 2026-04-08 | — | — | EP | disclosed |
| US-20250032636-A1 | Phage-Drug Conjugate | UNIV SYDNEY (AU) | 2025-01-30 | — | — | US | disclosed |
| WO-2024243637-A1 | PHAGE-EXTRACELLULAR VESICLE CONJUGATE | THE UNIVERSITY OF SYDNEY (AU) | 2024-12-05 | — | — | WO | disclosed |
| EP-4440589-A1 | PHAGE-DRUG CONJUGATE | The University Of Sydney (AU) | 2024-10-09 | — | — | EP | disclosed |
| US-11986533-B2 | Macromonomers and bottle brush polymers for delivery of biological agents | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2024-05-21 | — | — | US | disclosed |
| WO-2023092196-A1 | PHAGE-DRUG CONJUGATE | THE UNIVERSITY OF SYDNEY (AU) | 2023-06-01 | — | — | WO | disclosed |
| US-20220339288-A1 | MACROMONOMERS AND BOTTLE BRUSH POLYMERS FOR DELIVERY OF BIOLOGICAL AGENTS | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2022-10-27 | — | — | US | disclosed |
| CN-109734925-B | Polymer fluorescence sensor for detecting hypochlorite based on porphyrin comparability, preparation method and application | 湖南科技大学 | 2021-02-02 | — | — | CN | disclosed |
| CN-109734925-B | Polymer fluorescence sensor for detecting hypochlorite based on porphyrin comparability, preparation method and application | 湖南科技大学 | 2021-02-02 | — | — | CN | disclosed |
| US-9914825-B2 | Modified heterophasic polyolefin composition | MILLIKEN & COMPANY (US) | 2018-03-13 | — | — | US | disclosed |
| US-20160145426-A1 | MODIFIED HETEROPHASIC POLYOLEFIN COMPOSITION | MILLIKEN & COMPANY | 2016-05-26 | — | — | US | disclosed |
| US-9175015-B2 | Gold nanoparticle conjugates and uses thereof | COLORADO SCHOOL OF MINES (US) | 2015-11-03 | — | — | US | disclosed |
| US-8337551-B2 | Biomedical devices | BAUSCH & LOMB INCORPORATED (US) | 2012-12-25 | — | — | US | disclosed |
| US-20120022180-A1 | BIOMEDICAL DEVICES | BAUSCH & LOMB INCORPORATED | 2012-01-26 | — | — | US | disclosed |
| US-8043369-B2 | Biomedical devices | BAUSCH & LOMB INCORPORATED (US) | 2011-10-25 | — | — | US | disclosed |
| US-20100317809-A1 | Biomedical devices | BAUSCH & LOMB INCORPORATED (US) | 2010-12-16 | — | — | US | disclosed |
| US-20090060839-A1 | Gold Nanoparticle Conjugates and Uses Thereof | COLORADO SCHOOL OF MINES | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11986533-B2 | Macromonomers and bottle brush polymers for delivery of biological agents | HBB, PCNA, ARCN1 | ALDH1A1 2240/4885TDP1 2250/4885HDAC3 3098/4885 |
| US-20220339288-A1 | MACROMONOMERS AND BOTTLE BRUSH POLYMERS FOR DELIVERY OF BIOLOGICAL AGENTS | HBB, PCNA, ARCN1 | ALDH1A1 2256/4885TDP1 2251/4885HDAC3 3091/4885 |
| US-20250032636-A1 | Phage-Drug Conjugate | CLTA, DNPEP, CLTB | ALDH1A1 1304/4885TDP1 544/4885HDAC3 3314/4885 |
| US-20090060839-A1 | Gold Nanoparticle Conjugates and Uses Thereof | CD47, SELP, SELPLG | ALDH1A1 419/4885TDP1 1277/4885HDAC3 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.